6/24/2020 8:33:29 AM
Lilly Launches Program "Know Before The Low™" For People With Diabetes To Recognize And Share Their Signs And Symptoms
6/18/2020 8:12:43 AM
Eli Lilly Canada Begins Phase 3 Clinical Trial With Baricitinib For Hospitalized COVID-19 Patients
6/17/2020 6:47:24 AM
Lilly Says Emgality Reduces Total Pain Burden In Recent Analysis Of Patients With Episodic And Chronic Migraine
6/16/2020 11:06:13 AM
Lilly's Study Reveals Less Than 30% Of People Living With Migraine Take Recommended Prescription Medications
6/16/2020 6:48:57 AM
Lilly Says Verzenio In Combination With Standard Adjuvant Endocrine Therapy Meets Primary Endpoint Of IDFS
6/15/2020 10:50:55 PM
FDA Oks Lyumjev,Lilly' Rapid-acting Insulin Indicated To Improve Glycemic Control In Adults With Type 1, Type 2 Diabetes
6/15/2020 6:46:33 AM
Lilly Begins Phase 3 Clinical Trial With Baricitinib For Hospitalized COVID-19 Patients
6/13/2020 12:04:30 PM
Lilly Presents Data That Trulicity Demonstrates Significantly Higher Adherence And More Persistence Versus BCise Pen
6/13/2020 12:02:33 PM
Eli Lilly And Lilly Foundation Pledge $25 Mln And 25,000 Volunteer Hours Over Five Years To Combat Racial Injustice
6/9/2020 6:48:34 AM
Lilly Says First Patient Dose Delivered For Tirzepatide Cardiovascular Outcomes Trial
6/8/2020 7:17:31 AM
Junshi Biosciences Conducting Phase 1 Study In China With Lilly To Imminently Begin Phase 1 Study In The United States